Exhibit 99.84
Village Farms International, Inc.
Condensed Consolidated Interim Financial Statements
Three and Six Months Ended June 30, 2018 and 2017
(Unaudited)
Village Farms International, Inc.
Condensed Consolidated Interim Statements of Financial Position
(In thousands of United States dollars)
(Unaudited)
June 30, 2018 | December 31, 2017 | |||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 12,933 | $ | 7,091 | ||||
Trade receivables | 14,470 | 11,259 | ||||||
Other receivables | 1,879 | 1,982 | ||||||
Inventories | 18,567 | 17,309 | ||||||
Income taxes receivable | 246 | 246 | ||||||
Prepaid expenses and deposits | 1,031 | 564 | ||||||
Biological asset | 6,920 | 4,405 | ||||||
|
|
|
| |||||
Total current assets | 56,046 | 42,856 | ||||||
|
|
|
| |||||
Non-current assets | ||||||||
Property, plant and equipment | 79,516 | 81,754 | ||||||
Investment in joint venture | 15,386 | 15,727 | ||||||
Other assets | 1,996 | 2,004 | ||||||
|
|
|
| |||||
Total assets | $ | 152,944 | $ | 142,341 | ||||
|
|
|
| |||||
LIABILITIES | ||||||||
Current liabilities | ||||||||
Trade payables | $ | 10,780 | $ | 12,952 | ||||
Accrued liabilities | 6,656 | 3,793 | ||||||
Line of credit | 7,000 | — | ||||||
Current maturities of long-term debt | 3,440 | 2,620 | ||||||
Current maturities of capital lease obligations | 57 | 72 | ||||||
|
|
|
| |||||
Total current liabilities | 27,933 | 19,437 | ||||||
|
|
|
| |||||
Non-current liabilities | ||||||||
Long-term debt | 34,203 | 35,760 | ||||||
Long-term maturities of capital lease obligations | 160 | 179 | ||||||
Deferred tax liability | 4,006 | 4,825 | ||||||
Deferred compensation | 1,100 | 1,097 | ||||||
|
|
|
| |||||
Total liabilities | 67,402 | 61,298 | ||||||
|
|
|
| |||||
SHAREHOLDERS’ EQUITY | ||||||||
Share capital | 44,133 | 36,115 | ||||||
Contributed surplus | 1,982 | 1,726 | ||||||
Revaluation surplus | 4,321 | 4,321 | ||||||
Accumulated other comprehensive loss | (480 | ) | (391 | ) | ||||
Retained earnings | 35,586 | 39,272 | ||||||
|
|
|
| |||||
Total shareholders’ equity | 85,542 | 81,043 | ||||||
|
|
|
| |||||
Total liabilities and shareholders’ equity | $ | 152,944 | $ | 142,341 | ||||
|
|
|
|
The accompanying notes are an integral part of these condensed consolidated interim financial statements.
2
Village Farms International, Inc.
Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity
For the Six Months Ended June 30, 2018 and 2017
(In thousands of United States dollars, except for shares outstanding)
(Unaudited)
Number of Common Shares | Share Capital | Contributed Surplus | Revaluation Surplus | Accumulated Other Comprehensive Loss | Retained Earnings | Total Shareholders’ Equity | ||||||||||||||||||||||
Balance at January 1, 2017 | 38,882,945 | $ | 24,954 | $ | 1,392 | $ | 6,132 | $ | (541 | ) | $ | 35,450 | 67,387 | |||||||||||||||
Shares issued on exercise of stock options (note 17) | 33,334 | 26 | — | — | — | — | 26 | |||||||||||||||||||||
Issuance of common stock shares | 230,000 | — | — | — | — | — | — | |||||||||||||||||||||
Issuance of warrants for common shares | — | — | 148 | — | — | — | 148 | |||||||||||||||||||||
Share-based compensation (note 17) | — | 398 | 71 | — | — | — | 469 | |||||||||||||||||||||
Cumulative translation adjustment | — | — | — | — | 73 | — | 73 | |||||||||||||||||||||
Reclassification of previously recorded revaluation gain of land, net of tax (note 6) | — | — | — | (1,811 | ) | — | — | (1,811 | ) | |||||||||||||||||||
Net income | — | — | — | — | — | 4,135 | 4,135 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Balance at June 30, 2017 | 39,146,279 | 25,378 | 1,611 | 4,321 | (468 | ) | 39,585 | 70,427 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Balance at January 1, 2018 (restated—note 3) | 42,242,612 | 36,115 | 1,726 | 4,321 | (391 | ) | 39,012 | 80,783 | ||||||||||||||||||||
Shares issued on exercise of stock options (note 17) | 342,733 | 263 | — | — | — | — | 263 | |||||||||||||||||||||
Shares issued pursuant to private placement of common stock shares, net of issuance costs | 1,886,793 | 7,755 | — | — | — | — | 7,755 | |||||||||||||||||||||
Share-based compensation (note 17) | — | — | 256 | — | — | — | 256 | |||||||||||||||||||||
Cumulative translation adjustment | — | — | — | — | (89 | ) | — | (89 | ) | |||||||||||||||||||
Net loss | — | — | — | — | — | (3,426 | ) | (3,426 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Balance at June 30, 2017 | 44,472,138 | $ | 44,133 | $ | 1,982 | $ | 4,321 | $ | (480 | ) | $ | 35,586 | $ | 85,542 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these condensed consolidated interim financial statements.
3
Village Farms International, Inc.
Condensed Consolidated Interim Statements of (Loss) Income and Comprehensive Income
For the Three and Six Months Ended June 30, 2018 and 2017
(In thousands of United States dollars, except per share data)
(Unaudited)
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Sales | $ | 42,039 | $ | 45,530 | $ | 71,529 | $ | 76,807 | ||||||||
Cost of sales | (41,150 | ) | (42,805 | ) | (67,053 | ) | (70,125 | ) | ||||||||
Change in biological asset | 856 | (701 | ) | 197 | (1,346 | ) | ||||||||||
Selling, general and administrative expenses | (3,688 | ) | (3,425 | ) | (7,045 | ) | (6,608 | ) | ||||||||
Stock compensation expense | (138 | ) | (428 | ) | (256 | ) | (469 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Loss from operations | (2,081 | ) | (1,829 | ) | (2,628 | ) | (1,741 | ) | ||||||||
Interest expense | 691 | 695 | 1,289 | 1,327 | ||||||||||||
Foreign exchange loss (gain) | 21 | (13 | ) | 14 | 1 | |||||||||||
Other income | (26 | ) | (15 | ) | (44 | ) | (41 | ) | ||||||||
Share of loss from joint venture | 104 | — | 341 | — | ||||||||||||
Gain on sale of assets | — | (8,572 | ) | — | (8,564 | ) | ||||||||||
|
|
|
|
|
|
|
| |||||||||
(Loss) income before income taxes | (2,871 | ) | 6,076 | (4,228 | ) | 5,536 | ||||||||||
(Recovery of) provision for income taxes | (589 | ) | 1,751 | (802 | ) | 1,401 | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Net (loss) income | $ | (2,282 | ) | $ | 4,325 | $ | (3,426 | ) | $ | 4,135 | ||||||
|
|
|
|
|
|
|
| |||||||||
Basic (loss) income per share | $ | (0.05 | ) | $ | 0.11 | $ | (0.08 | ) | $ | 0.11 | ||||||
|
|
|
|
|
|
|
| |||||||||
Diluted (loss) income per share | $ | (0.05 | ) | $ | 0.11 | $ | (0.08 | ) | $ | 0.10 | ||||||
|
|
|
|
|
|
|
| |||||||||
Other comprehensive (loss) income: | ||||||||||||||||
Foreign currency translation adjustment | (34 | ) | 60 | (89 | ) | 73 | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Comprehensive (loss) income | $ | (2,316 | ) | $ | 4,385 | $ | (3,515 | ) | $ | 4,208 | ||||||
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these condensed consolidated interim financial statements.
4
Village Farms International, Inc.
Condensed Consolidated Interim Statements of Cash Flows
For the Three and Six Months Ended June 30, 2018 and 2017
(In thousands of United States dollars)
(Unaudited)
Three Months Ended March 31, | Three Months Ended December 31, | |||||||||||||||
2018 | 2017 | 2017 | 2016 | |||||||||||||
Cash flows used in operating activities: | ||||||||||||||||
Net loss | $ | (2,282 | ) | $ | 4,325 | $ | (3,426 | ) | $ | 4,135 | ||||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||||||
Depreciation and amortization | 1,722 | 1,949 | 3,523 | 3,900 | ||||||||||||
Amortization of deferred charges | — | 18 | — | 36 | ||||||||||||
Loss on sale of assets | — | (8,572 | ) | — | (8,564 | ) | ||||||||||
Share of loss from joint venture | 104 | — | 341 | — | ||||||||||||
Interest paid | 691 | 670 | 1,289 | 1,280 | ||||||||||||
Share-based compensation | 138 | 428 | 256 | 469 | ||||||||||||
Deferred income taxes | (604 | ) | 1,751 | (819 | ) | 1,401 | ||||||||||
Change in biological asset | (856 | ) | 701 | (197 | ) | 1,346 | ||||||||||
Changes in non-cash working capital items | 932 | 1,269 | (6,458 | ) | (6,077 | ) | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Net cash used in operating activities | (155 | ) | 2,539 | (5,491 | ) | (2,074 | ) | |||||||||
|
|
|
|
|
|
|
| |||||||||
Cash flows used in investing activities: | ||||||||||||||||
Purchases of property, plant and equipment | (1,092 | ) | (562 | ) | (1,440 | ) | (993 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Net cash used in investing activities | (1,092 | ) | (562 | ) | (1,440 | ) | (993 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Cash flows provided by financing activities: | ||||||||||||||||
Proceeds from borrowings | 4,000 | 1,000 | 7,000 | 6,000 | ||||||||||||
Repayments on borrowings | (840 | ) | (818 | ) | (917 | ) | (1,656 | ) | ||||||||
Interest paid on long-term debt | (691 | ) | (670 | ) | (1,289 | ) | (1,280 | ) | ||||||||
Proceeds from issuance of common stock pursuant to private placement, net | 7,755 | — | 7,755 | — | ||||||||||||
Proceeds from exercise of stock options | 94 | 26 | 263 | 26 | ||||||||||||
Payments on capital lease obligations | (17 | ) | (9 | ) | (34 | ) | (22 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Net cash provided by financing activities | 10,301 | (471 | ) | �� | 12,778 | 3,068 | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Effect of exchange rate changes on cash and cash equivalents | 10 | 3 | (5 | ) | 4 | |||||||||||
|
|
|
|
|
|
|
| |||||||||
Net decrease in cash and cash equivalents | 9,064 | 1,509 | 5,842 | 5 | ||||||||||||
Cash and cash equivalents, beginning of year | 3,869 | 3,869 | 7,091 | 5,373 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Cash and cash equivalents, end of year | $ | 12,933 | $ | 5,378 | $ | 12,933 | $ | 5,378 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Supplemental cash flow information: | ||||||||||||||||
Income taxes paid | $ | — | $ | 286 | $ | — | $ | 1,148 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Supplemental disclosure of non-cash information: | ||||||||||||||||
Purchases of capital expenditures by financing capital lease | $ | — | $ | 126 | $ | — | $ | 126 | ||||||||
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these condensed consolidated interim financial statements.
5
VILLAGE FARMS INTERNATIONAL, INC.
Notes to Condensed Consolidated Interim Financial Statements for the
Three and Six Months Ended June 30, 2018 and 2017
(In thousands of United States dollars, except per share amounts and unless otherwise noted)
1 | NATURE OF OPERATIONS |
Village Farms International, Inc. (“VFF” the parent company, together with its subsidiaries, the “Company”) is incorporated under the Canada Business Corporation Act. VFF’s principal operating subsidiaries as at June 30, 2018 are Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”), and VF Clean Energy, Inc (“VFCE”). The address of the registered office of VFF is 4700 80th Street, Delta, British Columbia, Canada, V4K 3N3. VFF owns a 50% equity interest in Pure Sunfarms Corp. (“Pure Sunfarms”), which is recorded as Investment in Joint Venture (note 7).
The Company’s shares are listed on the Toronto Stock Exchange under the symbol VFF and are also traded in the United States on the OTCQX® Best Market under the symbol VFFIF.
The Company, through its subsidiaries VFCLP and VFLP, owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers, and cucumbers. The Company also markets and sells third party produce through its subsidiaries. The Company, through its subsidiary VFCE, owns and operates a 7.0 MW power plant that generates electricity. In addition, the Company’s joint venture, Pure Sunfarms, is in the start up stage of becoming a producer and supplier of cannabis products to be sold to wholesalers, distributors and retailers across Canada and internationally.
2 | BASIS OF PRESENTATION |
Statement of Compliance
The Company’s unaudited condensed consolidated interim financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) and its interpretations, as issued by the International Accounting Standards Board (“IASB”). These condensed consolidated interim financial statements are prepared in accordance with International Accounting Standard (“IAS”) 34, Interim Financial Reporting. They do not include all of the information required for full annual financial statement disclosures, and should be read in conjunction with the Company’s audited annual consolidated financial statements for the year ended December 31, 2017, which were prepared in accordance with IFRS.
Basis of Presentation
The condensed consolidated interim financial statements are prepared on a going concern basis. The accounting policies have been applied consistently in all material respects. These condensed consolidated interim financial statements have been prepared by applying the same accounting policies, assessments of estimates and judgments, and methods of computation as compared with the most recent annual consolidated financial statements.
Basis of Measurement
The condensed consolidated interim financial statements (“interim financial statements”) have been prepared on the historical cost basis except for the following material items in the condensed consolidated interim statement of financial position (“interim statement of financial position”):
• | biological assets are measured at fair value less costs to sell; |
• | land is valued at fair market value; and |
• | available-for-sale financial assets are measured at fair value. |
Functional and Presentation Currency
These condensed consolidated interim financial statements are presented in United States dollars (“U.S. dollars”), which is the Company’s primary functional currency. VFCE’s functional currency is Canadian dollars and conversion to U.S. dollars is performed in accordance with IAS 21, The Effects of Changes in Foreign Exchange Rates. All financial information presented in U.S. dollars has been rounded to the nearest thousands, except per share amounts.
6
VILLAGE FARMS INTERNATIONAL, INC.
Notes to Condensed Consolidated Interim Financial Statements for the
Three and Six Months Ended June 30, 2018 and 2017
(In thousands of United States dollars, except per share amounts and unless otherwise noted)
3 | CHANGES IN ACCOUNTING POLICIES |
The Company has adopted the following new and revised standards and changes in accounting policies, along with any consequential amendments as at January 1, 2018. These changes were made in accordance with the applicable transitional provisions.
IFRS 9, Financial Instruments replaced the current IAS 39, Financial Instruments Recognition and Measurement. This standard sets out revised guidance for classifying and measuring financial assets and liabilities, introduces a new expected credit loss model for calculating impairment of financial assets and includes a reformed approach to hedge accounting. The standard also requires that when a financial liability at amortized cost is modified or exchanged, and such modification or exchange does not result in de-recognition, that the adjustment to the amortized cost of the financial liability is recognized in profit or loss. As a result of the Company’s adoption of IFRS 9, effective January 1, 2018, prior year financial statements had to be restated. IFRS 9 was adopted without restating comparative information. The reclassifications arising from the new rules are therefore not reflected in the statement of financial position as at December 31, 2017, but are recognized in the opening statement of financial position on January 1, 2018.
Following the adoption of IFRS 9, the Company could no longer defer and amortize financing fees that resulted from the refinancing of borrowings in periods prior to January 1, 2018. As a result, the Company has restated the beginning balances noted in the table below to properly account for $260 of financing fees in accordance with IFRS 9. The standard was applied retrospectively therefore approximately $260 of deferred financing costs, net of accumulated amortization, remain netted against long-term debt on the consolidated statement of financial position, as at December 31, 2017.
The following tables show the adjustments recognized for each individual line item. Line items that were not affected by the changes have not been included. As a result, the sub-totals and totals disclosed cannot be recalculated from the numbers provided.
December 31, 2017 As originally presented | IFRS 9 Adjustments | January 1, 2018 Restated | ||||||||||
Statement of Financial Position (extract) | ||||||||||||
Non-current liabilities | ||||||||||||
Long-term debt | $ | 35,760 | $ | 260 | $ | 36,020 | ||||||
|
|
|
|
|
| |||||||
Total liabilities | 61,298 | 260 | 61,558 | |||||||||
|
|
|
|
|
| |||||||
Shareholders’ Equity | ||||||||||||
Retained earnings | 39,272 | (260 | ) | 39,012 | ||||||||
|
|
|
|
|
| |||||||
Total shareholders’ equity | $ | 81,043 | (260 | ) | $ | 80,783 | ||||||
|
|
|
|
|
| |||||||
Statements of Income (Loss) and Comprehensive Income (extract) | ||||||||||||
Interest expense | $ | 2,695 | $ | 260 | $ | 2,955 | ||||||
|
|
|
|
|
| |||||||
Income (loss) before income taxes | 3,960 | (260 | ) | 3,700 | ||||||||
Provision for income taxes | 138 | — | 138 | |||||||||
|
|
|
|
|
| |||||||
Net income (loss) | $ | 3,822 | $ | (260 | ) | $ | 3,562 | |||||
|
|
|
|
|
| |||||||
Basic income (loss) per share | $ | 0.10 | $ | (0.01 | ) | $ | 0.09 | |||||
|
|
|
|
|
| |||||||
Diluted income (loss) per share | $ | 0.10 | $ | (0.01 | ) | $ | 0.09 | |||||
|
|
|
|
|
|
7
VILLAGE FARMS INTERNATIONAL, INC.
Notes to Condensed Consolidated Interim Financial Statements for the
Three and Six Months Ended June 30, 2018 and 2017
(In thousands of United States dollars, except per share amounts and unless otherwise noted)
IFRS 15, Revenue from Contracts with Customers, replaces IAS 18, Revenue, and IAS 11, Construction Contracts, and the related Interpretations on revenue recognition. IFRS 15 establishes a single comprehensive model for recognizing revenues from contracts with customers. The standard requires revenue to be recognized in a manner that depicts the transfer of promised goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for transferring those goods and services.
The Company generates its revenue through the sale of produce, with standard shipping terms and discounts, and through the production and sale of power.
The Company’s produce revenue transactions consist of single performance obligations to transfer promised goods. Quantities to be delivered to the customer are determined at a point near the date of delivery through purchase orders it receive from the customer. The Company recognizes revenue when it has fulfilled a performance obligation, which is typically when the customer receives the goods and its performance obligation is complete. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring product. The amount of revenue recognized is reduced for estimated returns and other customer credits, such as discounts and rebates, based on the expected value to be realized. Payment terms are consistent with terms standard to the markets the Company serves. The Company maintains an allowance for doubtful accounts for the loss that would be incurred if a customer was unable to pay amounts due. The Company initially estimates the allowance required at the time of revenue recognition based on historical experience and makes changes to the allowance based on various factors, including changes in the customer’s financial condition or payment patterns.
The Company sells electricity to British Columbia Hydro and Power Authority. Revenues are recognized as the electricity is delivered to/consumed by the customer and is based on contractual usage rates and meter readings that measure electricity consumption.
The Company adopted IFRS 15, as of January 1, 2018, using the modified retrospective transition method, which involves not restating periods prior to the date of initial application. The application of IFRS 15 required no adjustment to the Company’s interim financial statements for the three and six months ended June 30, 2018, as the amount and timing of substantially all of its revenues is, and will continue to be, recognized at a point in time.
Accounting Standards Issued and Not Applied
IFRS 16, Leases, issued in January 2016, replaces IAS 17, Leases, and related Interpretations. IFRS 16 establishes the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, i.e. the customer (lessee) and the supplier (lessor). IFRS 16 is effective for annual periods beginning on or after January 1, 2019, with early adoption permitted only if the Company also applies IFRS 15. Management is currently assessing the impact on the Company’s interim financial statements along with the timing of adoption of IFRS 16. Management expects that IFRS 16 will result in the following: a) an increase in assets and liabilities as fewer leases will be expensed as payments are made; b) an increase in depreciation expenses; and c) an increase in cash flow from operating activities as these lease payments will be recorded as financing outflows in the cash flow statements.
IFRS 11, Joint Arrangements, and IAS 28, Investments in Associates and Joint Ventures establishes the criteria for accounting for joint ventures. Investments in joint ventures are accounted for using the equity method. The equity method involves recording the initial investment at cost and subsequently adjusting the carrying value of the investment for the proportionate share of the profit or loss, other comprehensive income or loss and any other changes in the joint venture’s net assets such as dividends. At each consolidated statement of financial position date, the Company will consider whether there is objective evidence of impairment in joint venture. If there is such evidence, the Company will determine the amount of impairment to record, if any, in relation to the joint venture. IFRS is effective for annual periods beginning on or after January 1, 2019.
Amendment to IFRS 3, Business Combinations were issued to clarify that when an entity obtains control of a business that is a joint operation, it remeasures previously held interests in that business. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.
8
VILLAGE FARMS INTERNATIONAL, INC.
Notes to Condensed Consolidated Interim Financial Statements for the
Three and Six Months Ended June 30, 2018 and 2017
(In thousands of United States dollars, except per share amounts and unless otherwise noted)
Amendments to IAS 12, Income Taxes were issued to clarify that all income tax consequences of dividends (i.e. distribution of profits) should be recognized in profit or loss, regardless of how the tax arises. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.
Amendments to IAS 23, Borrowing Costs were issued to clarify that if any specific borrowing remains outstanding after the related asset is ready for its intended use or sale, that borrowing becomes part of the funds that an entity borrows generally when calculating the capitalization rate on general borrowings. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.
Further details of new accounting standards and potential impact on the Company can be found in the Company’s consolidated financial statements for the year ended December 31, 2017.
4 | INVENTORIES |
June 30, 2018 | December 31, 2017 | |||||||
Deferred crop costs | $ | 22,366 | $ | 19,070 | ||||
Purchased produce inventory | 644 | 396 | ||||||
Biological asset adjustment (note 5) | (4,530 | ) | (2,212 | ) | ||||
Spare parts inventory | 87 | 55 | ||||||
|
|
|
| |||||
$ | 18,567 | $ | 17,309 | |||||
|
|
|
|
The cost of inventories recognized as expense and included in cost of sales for the three months ended June 30, 2018 amounted to $34,375 (2017 - $37,192) and $54,580 for the six months ended June 30, 2018 (2017 - $58,828). The biological asset adjustment reclassifies actual costs incurred for the biological asset from inventories to biological asset on the interim statement of financial position.
5 | BIOLOGICAL ASSET |
Information about the biological asset presented on the consolidated statements of financial position and in the consolidated statements of income (loss) is as follows:
June 30, 2018 | December 31, 2017 | June 30, 2017 | ||||||||||
Estimated sales value–biological asset | $ | 12,803 | $ | 7,937 | $ | 14,639 | ||||||
Less | ||||||||||||
Estimated remaining costs to complete | 5,114 | 3,043 | 7,132 | |||||||||
Estimated selling costs | 769 | 489 | 751 | |||||||||
|
|
|
|
|
| |||||||
Fair value of biological asset less costs to sell | 6,920 | 4,405 | 6,756 | |||||||||
Less actual costs | 4,530 | 2,212 | 6,172 | |||||||||
|
|
|
|
|
| |||||||
Increase in fair value of biological asset over cost | 2,390 | 2,193 | 584 | |||||||||
Fair value over cost of harvested and sold biological asset - beginning of year | 2,193 | 1,928 | 1,930 | |||||||||
|
|
|
|
|
| |||||||
Change in biological asset | $ | 197 | $ | 265 | $ | (1,346 | ) | |||||
|
|
|
|
|
|
9
VILLAGE FARMS INTERNATIONAL, INC.
Notes to Condensed Consolidated Interim Financial Statements for the
Three and Six Months Ended June 30, 2018 and 2017
(In thousands of United States dollars, except per share amounts and unless otherwise noted)
6 | PROPERTY, PLANT AND EQUIPMENT |
Property, plant and equipment consist of the following:
Land | Leasehold and land improve- ments | Buildings | Machinery and Equipment | Construction in process | Total | |||||||||||||||||||
At December 31, 2017 |
| |||||||||||||||||||||||
Cost | $ | 9,112 | $ | 3,820 | $ | 77,029 | $ | 63,237 | $ | 468 | $ | 153,666 | ||||||||||||
Accumulated depreciation | — | (2,223 | ) | (33,685 | ) | (36,004 | ) | — | (71,912 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Net book value | $ | 9,112 | $ | 1,597 | $ | 43,344 | $ | 27,233 | $ | 468 | $ | 81,754 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Six months ended June 30, 2018 |
| |||||||||||||||||||||||
Opening net book value | $ | 9,112 | $ | 1,597 | $ | 43,344 | $ | 27,233 | $ | 468 | $ | 81,754 | ||||||||||||
Additions (transfers) | — | — | — | 233 | 1,417 | 1,650 | ||||||||||||||||||
Placed in service | — | — | — | 874 | (1,029 | ) | (155 | ) | ||||||||||||||||
Disposals (expense) | (65 | ) | — | — | — | (30 | ) | (95 | ) | |||||||||||||||
Depreciation expense | — | (42 | ) | (1,333 | ) | (2,148 | ) | — | (3,523 | ) | ||||||||||||||
FX translation adjustment | — | — | (15 | ) | (140 | ) | 40 | (115 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Closing net book value | $ | 9,047 | $ | 1,555 | $ | 41,996 | $ | 26,052 | $ | 866 | $ | 79,516 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
At June 30, 2018 |
| |||||||||||||||||||||||
Cost | $ | 9,047 | $ | 3,820 | $ | 77,007 | $ | 64,112 | $ | 866 | $ | 154,852 | ||||||||||||
Accumulated depreciation | — | (2,265 | ) | (35,011 | ) | (38,060 | ) | — | (75,336 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Net book value | $ | 9,047 | $ | 1,555 | $ | 41,996 | $ | 26,052 | $ | 866 | $ | 79,516 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation related to the greenhouse facilities and equipment is expensed in cost of sales. Land is the only item of property, plant and equipment that is stated at fair values. As at December 31, 2017, land, greenhouse buildings, and greenhouse equipment at Delta 3 were contributed as the Company’s investment in the joint venture transaction (note 7). The revaluation surplus related to Delta 3 of $1.8 million, net of taxes, that was previously recorded as a component of equity, was reclassified and included as part of the gain on disposal of assets recorded in the condensed consolidated interim statements of loss.
7 | INVESTMENT IN JOINT VENTURE |
On June 6, 2017, the Company entered into an agreement to form Pure Sunfarms Corp. (“Pure Sunfarms”), a B.C. corporation, with Emerald Health Therapeutics Inc. (“Emerald”). The purpose of Pure Sunfarms is to pursue large-scale cannabis production in Canada. Village Farms has a 50% ownership interest in Pure Sunfarms in the form of common shares. The Company has concluded that the agreement constitutes a joint arrangement where joint control is shared with Emerald and therefore has accounted for Pure Sunfarms in accordance with IFRS 11 and IAS 28, using the equity method.
As at June 30, 2018 the Investment in Joint Venture of $15.4 million (December 31, 2017 - $15.7 million) is recorded in the condensed consolidated interim statement of financial position. For the three months ended June 30, 2018, the Company’s share of net loss from joint venture totaled $104 (CA$130) (2017 - $nil) and for the six months ended June 30, 2018, the Company’s share of net loss from joint venture totaled $341 (CA$432) (2017 - $nil), which is recorded in the condensed consolidated interim statement of loss.
The Company’s share of the joint venture consists of the following (in $000’s of USD):
Balance, January 1, 2018 | $ | 15,727 | ||
Share of loss | (341 | ) | ||
|
| |||
Balance, June 30, 2018 | $ | 15,386 | ||
|
|
10
VILLAGE FARMS INTERNATIONAL, INC.
Notes to Condensed Consolidated Interim Financial Statements for the
Three and Six Months Ended June 30, 2018 and 2017
(In thousands of United States dollars, except per share amounts and unless otherwise noted)
Summarized financial information of Pure Sunfarms (in $000’s of CAD):
June 30, 2018 | December 31, 2017 | |||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 791 | $ | 2,907 | ||||
Other current assets | 3,483 | 475 | ||||||
Non-current assets | 43,386 | 23,144 | ||||||
Current liabilities | (9,170 | ) | (1,171 | ) | ||||
|
|
|
| |||||
Net assets | $ | 38,490 | $ | 25,355 | ||||
|
|
|
|
June 30, 2018 | December 31, 2017 | |||||||
Reconciliation of net assets: | ||||||||
Accumulated deficit | $ | (1,510 | ) | $ | (645 | ) | ||
Contributions from joint venture partners | 40,000 | 26,000 | ||||||
|
|
|
| |||||
Net assets | $ | 38,490 | $ | 25,355 | ||||
|
|
|
|
Three Months Ended June 30, 2018 | Six Months Ended June 30, 2018 | |||||||
Revenue | $ | — | $ | — | ||||
Selling, general and administrative expenses | (761 | ) | (1,315 | ) | ||||
Change in fair value of bio-asset | 422 | 422 | ||||||
Foreign exchange gain | 78 | 28 | ||||||
|
|
|
| |||||
Net loss | $ | (261 | ) | $ | (865 | ) | ||
|
|
|
|
8 | DEBT |
June 30, 2018 | December 31, 2017 | |||||||
Long-term debt: | ||||||||
Opening balance | $ | 38,380 | $ | 45,534 | ||||
IFRS adjustment for deferred financing fees (note 3) | 260 | — | ||||||
Proceeds from long-term debt | — | 306 | ||||||
Repayment of debt | (917 | ) | (7,320 | ) | ||||
Foreign currency translation | (80 | ) | 120 | |||||
|
|
|
| |||||
Closing balance | $ | 37,643 | $ | 38,640 | ||||
|
|
|
| |||||
Current portion | $ | 3,440 | $ | 2,620 | ||||
Non-current portion | 34,203 | 36,020 | ||||||
Less: Unamortized deferred transaction costs | — | (260 | ) | |||||
|
|
|
| |||||
$ | 37,643 | $ | 38,380 | |||||
|
|
|
|
Credit Facilities
The Company has a Term Loan financing agreement with a Canadian creditor (“FCC Loan”). The non-revolving variable rate term loan has a maturity date of May 1, 2021 and a balance of $35,925 as at June 30, 2018. The outstanding balance is repayable by way of monthly installments of principal and interest based on an amortization period of 15 years, with the balance and any accrued interest to be paid in full on May 1, 2021. As at June 30, 2018, borrowings under the FCC Loan agreement are subject to an interest rate of 6.85375% (December 31, 2017—5.88483%) which is determined based on the Company’s Debt to EBITDA ratio and the applicable LIBOR rate.
11
VILLAGE FARMS INTERNATIONAL, INC.
Notes to Condensed Consolidated Interim Financial Statements for the
Three and Six Months Ended June 30, 2018 and 2017
(In thousands of United States dollars, except per share amounts and unless otherwise noted)
The Company’s subsidiary VFCE has a loan agreement with a Canadian Chartered Bank that includes a non-revolving fixed rate loan of CA$3.0 million with a maturity date of June 2023 and fixed interest rate of 4.98%. As at June 30, 2018, the balance was US$1,642 (December 31, 2017 - US$1,658). The loan agreement also includes an uncommitted, non-revolving credit facility for up to CA$300 to cover Letters of Guarantee issued by the bank on behalf of the Company, with a maximum term of 365 days, renewable annually. The loan agreement also includes an uncommitted credit facility for up to CA$700 to support financing of certain capital expenditures. The Company received an initial advance of CA$250 in October 2017. Each advance is to be repaid on a five-year, straight-line amortization of principal, repaid in monthly installments of principal plus interest at an interest rate of CA$ prime rate plus 200 basis points. As at June 30, 2018, the balance was US$165 (December 31, 2017 - $192) .
The Company has a line of credit agreement with a Canadian Chartered Bank ( “Operating Loan”). The revolving Operating Loan has a line of credit up to CA$13,000 and variable interest rates with a maturity date on May 31, 2021, and is subject to margin requirements stipulated by the bank. As at June 30, 2018, US$7,000 was drawn on this facility (December 31, 2017 - $nil), which is available to a maximum of CA$13,000, less outstanding letters of credit totaling US$261 and CA$38.
The Company’s borrowings (“Credit Facilities”) are subject to certain positive and negative covenants. As at June 30, 2018 and December 31, 2017, the Company was in compliance with all covenants on its Credit Facilities.
Accrued interest payable on the credit facilities and loans as at June 30, 2018 was $220 (December 31, 2017 - $193) and these amounts are included in accrued liabilities in the interim statement of financial position.
The aggregate annual maturities of long-term debt for the next five years and thereafter are as follows:
The remainder of 2018 | $ | 1,694 | ||
2019 | 3,379 | |||
2020 | 3,374 | |||
2021 | 28,690 | |||
2022 | 345 | |||
Thereafter | 161 | |||
|
| |||
$ 37,643 | ||||
|
|
9 | FINANCIAL INSTRUMENTS |
The following table summarizes the carrying and fair value of the Company’s financial instruments:
June 30, 2018 | December 31, 2017 | |||||||
Cash and cash equivalents | $ | 12,933 | $ | 7,091 | ||||
Trade receivables | $ | 14,470 | $ | 11,259 | ||||
Other financial assets | $ | 2,353 | $ | 2,491 | ||||
Other financial liabilities | $ | 63,609 | $ | 56,718 |
Interest income, expense and gains and losses from loans, receivables and other financial liabilities are recognized in the condensed consolidated interim statements of loss. The following table summarizes interest income and expense for the three and six months ended June 30:
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Interest income earned on cash and cash equivalents | $ | 3 | $ | — | | $ | 3 | $ | — | | ||||||
Interest expense from other financial liabilities | $ | 688 | $ | 695 | | $ | 1,286 | $ | 1,327 |
Financial assets and liabilities are recognized on the consolidated interim statement of financial position at fair value in a hierarchy that is based on significance of the inputs used in making the measurements. The levels in the hierarchy are:
12
VILLAGE FARMS INTERNATIONAL, INC.
Notes to Condensed Consolidated Interim Financial Statements for the
Three and Six Months Ended June 30, 2018 and 2017
(In thousands of United States dollars, except per share amounts and unless otherwise noted)
• | Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities |
• | Level 2 - Inputs other than quoted prices included within level 1 that are observable for the asset or liability either directly (i.e., as prices) or indirectly (i.e., derived from prices) |
• | Level 3 - Inputs for the asset or liability that are not based on observable market data (i.e., unobservable inputs). |
Management of financial risks
The Company, through its financial assets and liabilities, is exposed to various risks. The following provides a measurement of some of these risks as at June 30, 2018 and December 31, 2017. The Company uses financial instruments only for risk management purposes, not for generating trading profit.
i) | Credit risk |
Credit risk is the risk that the Company will incur a loss due to the failure by its customers or other parties to meet their contractual obligations. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, trade receivables and other receivables. The Company limits its exposure to credit risk by placing its cash and cash equivalents with high credit quality financial institutions.
The Company’s trade receivables had two customers that represented more than 10% of the balance of trade receivables, representing 11.1% and 10.6% of the balance of trade receivables as at June 30, 2018 (2017 - one customer represented 10.0%). The Company believes that its trade receivables risk is limited due to the high credit quality of its customers and the protection afforded to the Company by the Perishable Agricultural Commodities Act (the “PACA”) for its sales in the United States, which represent approximately 85% of the Company’s annual sales. The PACA protection gives a claim filed under the PACA first lien on all PACA assets (which include cash and trade receivables). The PACA fosters trading practices in the marketing of fresh and frozen fruits and vegetables in interstate and foreign commerce. It prohibits unfair and fraudulent practices and provides a means of enforcing contracts. Historical write-offs have represented less than one-half of 1% of sales. The maximum amount of credit risk exposure is limited to the carrying amount of the balances on the interim financial statements.
Trade receivables for each customer were evaluated for collectability and an allowance for doubtful accounts has been estimated. As at June 30, 2018, the allowance for doubtful accounts balance was $50 (December 31, 2017 - $50). The Company has not recorded a bad debt expense during the three and six months ended June 30, 2018 (2017 - $nil).
As at June 30, 2018, 93.0% (December 2017 - 89.4%) of trade receivables were outstanding less than 30 days, 5.9% (December 2017 - 7.4%) were outstanding for between 30 and 90 days and the remaining 1.1% (December 2017 - 3.2%) were outstanding for more than 90 days. Trade receivables are considered past due based on the contract terms agreed to with a customer. Aged receivables that are past due are not considered impaired unless customer specific information indicates otherwise.
ii) | Interest rate risk |
Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt, for which the interest rates charged fluctuate based on the 90-day LIBOR rate. If interest rates had been 50 basis points higher, the net income during the six months ended June 30, 2018 would have been lower by $95. This represents $95 in increased interest expense (2017 - $107).
iii) | Foreign exchange risk |
As at June 30, 2018, the Canadian/U.S. foreign exchange rate was CA$1.00 = US$0.7609 (December 31, 2017 - US$0.7966). Assuming that all other variables remain constant, an increase of $0.10 in the Canadian dollar would have the following impact on the ending balances of certain consolidated statements of financial position items as at June 30, 2018 and December 31, 2017 with the net foreign exchange gain or loss directly impacting net income (loss) for the period.
13
VILLAGE FARMS INTERNATIONAL, INC.
Notes to Condensed Consolidated Interim Financial Statements for the
Three and Six Months Ended June 30, 2018 and 2017
(In thousands of United States dollars, except per share amounts and unless otherwise noted)
June 30, 2018 | December 31, 2017 | |||||||
Financial assets | ||||||||
Cash and cash equivalents | $ | 92 | $ | 287 | ||||
Trade receivables | 505 | 349 | ||||||
Financial liabilities | ||||||||
Trade payables and accrued liabilities | (643 | ) | (371 | ) | ||||
Loan payable | (216 | ) | (232 | ) | ||||
|
|
|
| |||||
Net foreign exchange (loss) gain | $ | (262 | ) | $ | 33 | |||
|
|
|
|
iv) | Liquidity risk |
Liquidity risk is the risk that the Company will not be able to meet its obligations as they fall due. The following are the contractual maturities of financial liabilities as at June 30, 2018:
Financial liabilities | Total | 1 year | 2-3 years | 4-5 years | More than 5 years | |||||||||||||||
Long-term debt | $ | 37,643 | $ | 3,440 | $ | 33,528 | $ | 675 | $ | — | ||||||||||
Line of credit | 7,000 | 7,000 | — | — | — | |||||||||||||||
Trade payables | 10,780 | 10,780 | — | — | — | |||||||||||||||
Accrued liabilities | 6,656 | 6,656 | — | — | — | |||||||||||||||
Obligation under capital lease | 217 | 57 | 160 | — | — | |||||||||||||||
Other liabilities | 1,100 | 733 | 367 | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Total | $ | 63,396 | $ | 28,666 | $ | 34,055 | $ | 675 | $ | — | ||||||||||
|
|
|
|
|
|
|
|
|
|
It is the Company’s intention to meet these obligations through the collection of current accounts receivable and cash from sales. If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing. In addition, as at June 30, 2018, the Company has an operating loan of up to CA$13,000, less an outstanding balance of US$7,000 and outstanding letters of credit totaling US$261 and CA$38.
v) | Fair values |
The carrying amount of short-term financial instruments, less provisions for impairment if applicable, is consistent with the fair value of such instruments. The Company’s debt bears a variable interest rate tied to market rates and therefore its carrying value approximates its fair value.
10 | RELATED PARTY TRANSACTIONS AND BALANCES |
As at June 30, 2018, the Company had amounts due from its joint venture, Pure Sunfarms, totaling $891 primarily for consulting services and the reimbursement of expenses which occurred in the year. These amounts were non-interest bearing and were due on demand. These amounts are included in other receivables in the interim statement of financial position.
Included in other assets as at June 30, 2018, is a $67 (December 31, 2017—$70) promissory note that represents the unpaid amount the Company advanced to an employee in connection with a relocation at the request of the Company.
14
11 | EXPENSES BY NATURE |
The following table outlines the Company’s significant expenses by nature:
Cost of sales | Three months ended June 30, | Six months ended June 30, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Purchased produce | $ | 11,581 | $ | 12,548 | $ | 19,767 | $ | 22,069 | ||||||||
Raw materials and consumables used | 12,829 | 13,383 | 16,265 | 17,691 | ||||||||||||
Depreciation and amortization | 1,694 | 1,916 | 3,465 | 3,831 | ||||||||||||
Transportation and storage | 5,905 | 5,400 | 10,441 | 9,767 | ||||||||||||
Employee compensation and benefits | 9,141 | 9,558 | 17,115 | 16,767 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
$ | 41,150 | $ | 42,805 | $ | 67,053 | $ | 70,125 | |||||||||
|
|
|
|
|
|
|
|
Selling, general and administrative expenses | Three months ended June 30, | Six months ended June 30, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Employee benefits – salaries and short-term benefits | $ | 2,294 | $ | 2,535 | $ | 4,464 | $ | 4,650 | ||||||||
Marketing | 92 | 128 | 178 | 212 | ||||||||||||
Professional services | 659 | 366 | 1,070 | 611 | ||||||||||||
Office expenses | 449 | 426 | 891 | 800 | ||||||||||||
Other | 332 | 398 | 698 | 804 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
$ | 3,826 | $ | 3,853 | $ | 7,301 | $ | 7,077 | |||||||||
|
|
|
|
|
|
|
|
Employee compensation and benefits | Three months ended June 30, | Six months ended June 30, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Salaries and short-term employee benefits | $ | 11,297 | $ | 11,665 | $ | 21,323 | $ | 20,948 | ||||||||
Share-based compensation | 138 | 428 | 256 | 469 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
$ | 11,435 | $ | 12,093 | $ | 21,579 | $ | 21,417 | |||||||||
|
|
|
|
|
|
|
|
12 | DEFERRED INCOME TAX |
Income tax expense is recognized based on management’s best estimate of the weighted average annual income tax rate expected for the full financial year. The estimated average annual rate used for the six months ended June 30, 2018 was 25%, excluding the change in biological asset as reported on the condensed consolidated interim statements of loss, and 30% for the six months ended June 30, 2017.
13 | CHANGES IN NON-CASH WORKING CAPITAL ITEMS |
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Trade receivables | $ | (5,366 | ) | $ | (5,650 | ) | $ | (3,219 | ) | $ | (5,183 | ) | ||||
Inventories | (697 | ) | 3,794 | (2,870 | ) | 1,475 | ||||||||||
Inventories reclassified to biological asset | 1,332 | (1,173 | ) | (921 | ) | (3,657 | ) | |||||||||
Other receivables | (58 | ) | (182 | ) | — | (126 | ) | |||||||||
Prepaid expenses and deposits | 267 | (402 | ) | 109 | (717 | ) | ||||||||||
Trade payables | 2,606 | 2,991 | (2,150 | ) | 396 | |||||||||||
Accrued liabilities and taxes | 3,037 | 1,885 | 3,081 | 1,711 | ||||||||||||
Other assets/other liabilities, net | (189 | ) | 6 | (488 | ) | 24 | ||||||||||
|
|
|
|
|
|
|
| |||||||||
$ | 932 | $ | 1,269 | $ | (6,458 | ) | $ | (6,077 | ) | |||||||
|
|
|
|
|
|
|
|
14 | SEGMENT AND GEOGRAPHIC INFORMATION |
The Company’s two reporting segments include the Produce business and the Energy business. The Produce business produces, markets, and sells the product group which consists of premium quality tomatoes, bell peppers and cucumbers. The Energy business produces power that it sells per a long-term contract to its one customer.
The Company’s primary operations are in the United States and Canada. Net sales by the countries in which its customers are located are as follows:
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Net Sales | ||||||||||||||||
United States | $ | 32,892 | $ | 36,861 | $ | 60,318 | $ | 65,038 | ||||||||
Canada | 8,693 | 8,196 | 10,232 | 10,810 | ||||||||||||
Energy - Canada | 454 | 473 | 979 | 959 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
$ | 42,039 | $ | 45,530 | $ | 71,529 | $ | 76,807 | |||||||||
|
|
|
|
|
|
|
|
The Company’s property, plant and equipment, net of accumulated depreciation, are located as follows:
June 30, 2018 | December 31, 2017 | |||||||
United States | $ | 44,929 | $ | 46,922 | ||||
Canada | 30,632 | 31,183 | ||||||
Energy - Canada | 3,955 | 3,649 | ||||||
|
|
|
| |||||
$ | 79,516 | $ | 81,754 | |||||
|
|
|
|
Depreciation and amortization charges in the Produce business for the three and six months ended June 30, 2018 were $1,534 (2017 - $1,757) and $3,112 (2017 - $3,522), respectively. Depreciation and amortization charges in the Energy business for the three and six months ended June 30, 2018 were $188 (2017 - $192) and $411 (2017 - $378), respectively.
15 | LOSS PER SHARE |
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Net (loss) income attributable to owners of the Company | $ | (2,282 | ) | $ | 4,325 | $ | (3,426 | ) | $ | 4,135 | ||||||
Weighted average number of common shares outstanding (thousands) | 43,336 | 39,146 | 42,894 | 39,146 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Basic (loss) earnings per share | $ | (0.05 | ) | $ | 0.11 | $ | (0.08 | ) | $ | 0.11 | ||||||
|
|
|
|
|
|
|
| |||||||||
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Net (loss) income attributable to owners of the Company | $ | (2,282 | ) | $ | 4,325 | $ | (3,426 | ) | $ | 4,135 | ||||||
Weighted average number of common shares outstanding (thousands) | 43,336 | 39,146 | 42,894 | 39,146 | ||||||||||||
Adjustment for: | ||||||||||||||||
Share options (thousands) | — | 811 | — | 694 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Weighted average number of common shares outstanding for diluted earnings per share (thousands) | 43,336 | 39,957 | 42,894 | 39,840 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted (loss) earnings per share | $ | (0.05 | ) | $ | 0.11 | $ | (0.08 | ) | $ | 0.10 | ||||||
|
|
|
|
|
|
|
|
For the three and six months ended June 30, 2018, there were options to purchase 2,198 (2017 - 2,241) shares of the Company’s common stock that were excluded from the diluted loss per share computation because the impact of the assumed exercise of such stock options would have been anti-dilutive during the respective periods.
16 | CAPITAL DISCLOSURES |
The Company’s capital comprises net debt and equity:
June 30, 2018 | December 31, 2017 | |||||||
Total bank debt | $ | 37,643 | $ | 38,640 | ||||
Less cash and cash equivalents | (12,933 | ) | (7,091 | ) | ||||
|
|
|
| |||||
Net debt | 24,710 | 31,549 | ||||||
Total equity | 85,542 | 81,043 | ||||||
|
|
|
| |||||
$ | 110,252 | $ | 112,592 | |||||
|
|
|
|
It is the Company’s intention to meet its obligations through the collection of current accounts receivable and cash. As at June 30, 2018, the Company has an available operating loan up to CA$13,000, less US$7,000 drawn on the loan and US$261 and CA$38 outstanding letters of credit (as at December 31, 2017, $nil was outstanding on the operating loan, and US$333 and CA$38 outstanding on the letters of credit). As at June 30, 2018, the operating loan borrowing base was CA$3,430 based on a percentage of the Company’s outstanding accounts receivable less the issued letters of credit. If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing.
17 | SHARE-BASED COMPENSATION PLAN |
The Company has a share-based compensation plan. The maximum number of common shares that can be earned upon the exercise of earned performance-based restricted share units is equal to 10% of the aggregate number of common shares issued and outstanding from time to time. The term during which an option may be exercised is 10 years from the date of the grant. Options vest at a rate of 33% per year, beginning one year following the grant date of the options. Performance-based restricted share units are earned based on certain business milestones being achieved prior to a stated date. If the performance does not occur prior to stated date, the restricted share units expire.
As at June 30, 2018 and December 31, 2017, there were 128,000 performance-based restricted share units outstanding with a weighted average grant date fair value of CA$2.82. In June 2018, 979,000 performance-based restricted share units with a weighted average grant date fair value of CA$5.77 were issued to Village Farms employees. All were outstanding as at June 30, 2018.
Share-based compensation expense for the three and six months ended June 30, 2018 of $138 (2017 - $428) and $256 (2017 - $469), respectively, was recorded in selling, general and administrative expenses and the corresponding amount credited to contributed surplus.
18 | SUBSEQUENT EVENTS |
On July 5, 2018, the Company and Emerald Health Therapeutics Canada Inc. (together, the “Shareholders”) entered into a Shareholder Loan Agreement (the “Loan Agreement”) with Pure Sunfarms, whereby the Shareholders each contributed CA$5,000 in the form of a demand loan to Pure Sunfarms. The loan amounts will initially bear simple interest at the rate of 8% per annum, calculated semi-annually. Interest will accrue and be payable upon demand being made by either Shareholder.
17